What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate
Top Cited Papers
- 1 January 2018
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 286 (1), 186-195
- https://doi.org/10.1148/radiol.2017152877
Abstract
Purpose To characterize clinically important prostate cancers missed at multiparametric (MP) magnetic resonance (MR) imaging. Materials and Methods The local institutional review board approved this HIPAA-compliant retrospective single-center study, which included 100 consecutive patients who had undergone MP MR imaging and subsequent radical prostatectomy. A genitourinary pathologist blinded to MP MR findings outlined prostate cancers on whole-mount pathology slices. Two readers correlated mapped lesions with reports of prospectively read MP MR images. Readers were blinded to histopathology results during prospective reading. At histopathologic examination, 80 clinically unimportant lesions (t test was used to determine any demographic differences between patients with false-negative MP MR imaging findings and those with correct prospective identification of all lesions. Results Of the 162 lesions, 136 (84%) were correctly identified with MP MR imaging. Size of eight lesions was underestimated. Among the 26 (16%) lesions missed at MP MR imaging, Gleason score was 3+4 in 17 (65%), 4+3 in one (4%), 4+4 in seven (27%), and 4+5 in one (4%). Retrospective PI-RADS version 2 scores were assigned (PI-RADS 1, n = 8; PI-RADS 2, n = 7; PI-RADS 3, n = 6; and PI-RADS 4, n = 5). On a per-patient basis, MP MR imaging depicted clinically important prostate cancer in 99 of 100 patients. At least one clinically important tumor was missed in 26 (26%) patients, and lesion size was underestimated in eight (8%). Conclusion Clinically important lesions can be missed or their size can be underestimated at MP MR imaging. Of missed lesions, 58% were not seen or were characterized as benign findings at second-look analysis. Recognition of the limitations of MP MR imaging is important, and new approaches to reduce this false-negative rate are needed. © RSNA, 2017 Online supplemental material is available for this article.Keywords
This publication has 33 references indexed in Scilit:
- The past, present and future of minimally invasive therapy in urology: A review and speculative outlookMinimally Invasive Therapy & Allied Technologies, 2013
- Peripheral Zone Prostate Cancer Localization by Multiparametric Magnetic Resonance at 3 TInvestigative Radiology, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Multiparametric 3T Prostate Magnetic Resonance Imaging to Detect Cancer: Histopathological Correlation Using Prostatectomy Specimens Processed in Customized Magnetic Resonance Imaging Based MoldsJournal of Urology, 2011
- A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancerEuropean Journal of Radiology, 2010
- Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imagingJournal of Magnetic Resonance Imaging, 2010
- Prostate cancerThe Lancet, 2008
- Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancerUrology, 2004
- Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate Cancer. Results of a Multi-Institutional Cooperative TrialInvestigative Radiology, 1991